| Board Name | Posts By Wordsmith | Post Created |
|---|---|---|
| UNVC Univec Conglomerate Inc | When I first found this ticker the | 01/02/2020 9:37:48 PM |
| UNVC Univec Conglomerate Inc | Sorry Quest my bad. I assumed that | 12/30/2019 10:43:46 AM |
| UNVC Univec Conglomerate Inc | What is state of banking laws and h | 12/29/2019 6:29:05 PM |
| UNVC Univec Conglomerate Inc | It's a shame but senate passage wil | 09/20/2019 10:37:09 PM |
| UNVC Univec Conglomerate Inc | Faith. We are all stepping out on f | 09/19/2019 11:58:51 PM |
| UNVC Univec Conglomerate Inc | I believe the reason we don't have | 09/06/2019 2:53:55 PM |
| UNVC Univec Conglomerate Inc | Regarding big pharmaceutical lawsui | 08/28/2019 10:26:49 PM |
| VRUS Verus International, Inc. | I'm off topic posted on wrong ticke | 08/28/2019 10:03:57 PM |
| VRUS Verus International, Inc. | Opioid lawsuit I have a different t | 08/28/2019 9:49:05 PM |
| UNVC Univec Conglomerate Inc | Any one know what Dr said? | 06/20/2019 9:13:11 PM |
Recent Articles
- Turning Condo Ownership Into a Profitable Long-Term Investment
- How to Find the Perfect New Home in Your Desired Location
- Discover RubyReels: Australia’s Next Top Online Casino in 2025
- DeLeion Capital Seizes Opportunities in Crypto Landscape
- EU Takes Bold Steps to Secure Rare Earth Supply Chain
- What Investors Need to Know About Jasper Therapeutics Class Action
- KBR Investors Urged to Act Ahead of Class Action Deadline
- Trump's Rally in New Jersey: A Clash of Political Titans
- Discover the Excellence of Kratom Bird's Online Shopping Experience
- Avacta Unveils Promising Dual Payload Data from Cancer Therapies
- Exploring the Breakthrough Potential of BBO-10203 in Cancer Treatment
- AlphaTON Capital and Cyncado Therapeutics Advance Cancer Research
- Investor Insights: Key Stocks Sparking Discussions This Week
- Novartis Unveils Promising Results in Autoimmune Research
- Innovative CLN-978 Shows Promise for Autoimmune Treatments
- Innovative Advances in Rare Disease Care Highlighted by Sobi
- Cytokinetics Faces Class Action: What Investors Need to Know
- Innovative B Cell Treatment CLN-978 Shows Promising Data
- Exploring Elon Musk's Vision for a Future with Universal High Income
- The Digital Hotelier's Bold Move into the Americas Market
- BIMZELX® Insights: Three-Year Results in Rheumatology Showcase Progress
- Innovative CAR-Treg Therapy QEL-005 Set for Major Reveal
- KYV-101: A Promising New Therapy Option for Rheumatoid Arthritis
- Sify Technologies Delivers Strong Quarter with Robust Growth Metrics
- Sify Technologies Q2 FY 2025-26 Results: Growth Insights
- Quantum Corporation Class Action: Key Updates and Next Steps
- MoonBull ($MOBU) Achieves Presale Milestone and Engages Community
- Understanding Investor Rights: Telix Pharmaceuticals Class Action Details
- Unveiling Taiwan's Historical Legacy Through a Personal Journey
- Unlocking America's Hidden Mineral Wealth and Its Impact
- Phathom Pharmaceuticals' VOQUEZNA® Shows Promising GERD Relief
- Invest in Your Future: Class Action Details on V.F. Corp
- LiTime Unveils Innovative Lithium Solutions for Landscaping
- Grant Cardone Explores Future of Investments in Bitcoin and Real Estate
- MOVA Launches Innovative Smart Outdoor Tech at Equip Exposition
- Discover How MENU – ORDER AI is Transforming Healthy Dining
- Mutuum Finance Gears Up for V1 Protocol Launch: What to Expect
- Stock Movements: Beyond Meat, Intel, and Newmont's Earnings Impact
- Unlocking Vehicle Security with the LAMTTO DC22 Dash Camera
- Mutuum Finance Excels with Significant Funding as It Prepares for V1 Launch
- Uniting Hearts and Homes: A Mission to Save Pets in Miami
- Reviving Taiwan's History: A Journey Through Time and Sacrifice
- How a Heist Sparked a Creative Marketing Campaign for Böcker
- Exciting Week in Crypto: Insights from Coinbase and Market Movements
- Deepinder Goyal's $25 Million Vision for Human Longevity
- Impact of Trump Policies on Pennsylvania's Trade with Canada
- Concerns Rise Over Tesla's Future as BYD Outpaces Competition
- Revolutionary Phase 3 Trial Data Shows Promise for ITM-11
- Major Changes at X: Advertising Chief Nitti Departs Company
- Cardiovalve Targets CE Mark for Advanced Heart Valve Solutions


